Agilon Health initiated with bullish view at JMP Securities, here’s why

JMP Securities initiated coverage of Agilon Health with an Outperform rating and $18 price target. Agilon is a leading physician enablement company, helping independent primary care physicians, multispecialty practices, and health systems build globally capitated Medicare-centric business lines, the analyst tells investors in a research note. The firm likes the company’s capital-efficient model and focus on Medicare Advantage patients, and views primary care as an “ideal lever” for managing the health of patients and downstream healthcare costs.